nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—osteoarthritis—Prednisone—systemic lupus erythematosus	0.182	0.5	CpDpCtD
Meloxicam—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.182	0.5	CpDpCtD
Meloxicam—PTGS2—systemic lupus erythematosus	0.155	1	CbGaD
Meloxicam—PGD—Methotrexate—systemic lupus erythematosus	0.0659	0.192	CbGbCtD
Meloxicam—PTGS2—Dapsone—systemic lupus erythematosus	0.0308	0.0898	CbGbCtD
Meloxicam—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0267	0.0778	CbGbCtD
Meloxicam—PTGS1—Dapsone—systemic lupus erythematosus	0.026	0.0758	CbGbCtD
Meloxicam—PTGS2—Betamethasone—systemic lupus erythematosus	0.0229	0.0668	CbGbCtD
Meloxicam—ABCC4—Methotrexate—systemic lupus erythematosus	0.0182	0.0531	CbGbCtD
Meloxicam—CYP2C8—Dapsone—systemic lupus erythematosus	0.015	0.0437	CbGbCtD
Meloxicam—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0147	0.0428	CbGbCtD
Meloxicam—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0133	0.0388	CbGbCtD
Meloxicam—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.013	0.0379	CbGbCtD
Meloxicam—CYP2C9—Dapsone—systemic lupus erythematosus	0.0105	0.0305	CbGbCtD
Meloxicam—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0104	0.0304	CbGbCtD
Meloxicam—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00985	0.0287	CbGbCtD
Meloxicam—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00695	0.0203	CbGbCtD
Meloxicam—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00687	0.02	CbGbCtD
Meloxicam—CYP2C9—cardial valve—systemic lupus erythematosus	0.00656	0.202	CbGeAlD
Meloxicam—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00649	0.0189	CbGbCtD
Meloxicam—CYP3A4—Dapsone—systemic lupus erythematosus	0.00608	0.0177	CbGbCtD
Meloxicam—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00527	0.0154	CbGbCtD
Meloxicam—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00527	0.0154	CbGbCtD
Meloxicam—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00452	0.0132	CbGbCtD
Meloxicam—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00452	0.0132	CbGbCtD
Meloxicam—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00446	0.013	CbGbCtD
Meloxicam—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00423	0.0123	CbGbCtD
Meloxicam—CYP3A4—Prednisone—systemic lupus erythematosus	0.00421	0.0123	CbGbCtD
Meloxicam—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00399	0.0117	CbGbCtD
Meloxicam—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00263	0.00768	CbGbCtD
Meloxicam—PGD—blood plasma—systemic lupus erythematosus	0.00161	0.0497	CbGeAlD
Meloxicam—CYP2C9—urine—systemic lupus erythematosus	0.00142	0.0437	CbGeAlD
Meloxicam—ABCC4—blood plasma—systemic lupus erythematosus	0.00115	0.0353	CbGeAlD
Meloxicam—CYP3A4—urine—systemic lupus erythematosus	0.00108	0.0333	CbGeAlD
Meloxicam—PGD—connective tissue—systemic lupus erythematosus	0.000857	0.0264	CbGeAlD
Meloxicam—CYP2C8—blood plasma—systemic lupus erythematosus	0.000831	0.0256	CbGeAlD
Meloxicam—PGD—nephron tubule—systemic lupus erythematosus	0.00083	0.0256	CbGeAlD
Meloxicam—PGD—skin of body—systemic lupus erythematosus	0.000774	0.0239	CbGeAlD
Meloxicam—PTGS1—endothelium—systemic lupus erythematosus	0.000759	0.0234	CbGeAlD
Meloxicam—CYP2C9—blood plasma—systemic lupus erythematosus	0.000739	0.0228	CbGeAlD
Meloxicam—PGD—kidney—systemic lupus erythematosus	0.00073	0.0225	CbGeAlD
Meloxicam—PTGS2—endothelium—systemic lupus erythematosus	0.000726	0.0224	CbGeAlD
Meloxicam—PGD—cortex of kidney—systemic lupus erythematosus	0.000711	0.0219	CbGeAlD
Meloxicam—PTGS1—blood plasma—systemic lupus erythematosus	0.000674	0.0208	CbGeAlD
Meloxicam—PTGS2—blood plasma—systemic lupus erythematosus	0.000644	0.0199	CbGeAlD
Meloxicam—PGD—lymphoid tissue—systemic lupus erythematosus	0.000627	0.0193	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—systemic lupus erythematosus	0.000595	0.341	CrCbGaD
Meloxicam—ABCC4—nephron tubule—systemic lupus erythematosus	0.000591	0.0182	CbGeAlD
Meloxicam—PGD—tendon—systemic lupus erythematosus	0.000589	0.0182	CbGeAlD
Meloxicam—PGD—bone marrow—systemic lupus erythematosus	0.000571	0.0176	CbGeAlD
Meloxicam—CYP3A4—blood plasma—systemic lupus erythematosus	0.000563	0.0174	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—systemic lupus erythematosus	0.00053	0.304	CrCbGaD
Meloxicam—ABCC4—kidney—systemic lupus erythematosus	0.000519	0.016	CbGeAlD
Meloxicam—PGD—lung—systemic lupus erythematosus	0.000517	0.016	CbGeAlD
Meloxicam—ABCC4—cortex of kidney—systemic lupus erythematosus	0.000506	0.0156	CbGeAlD
Meloxicam—PGD—nervous system—systemic lupus erythematosus	0.000479	0.0148	CbGeAlD
Meloxicam—PGD—central nervous system—systemic lupus erythematosus	0.000461	0.0142	CbGeAlD
Meloxicam—ABCC4—tendon—systemic lupus erythematosus	0.000419	0.0129	CbGeAlD
Meloxicam—ABCC4—bone marrow—systemic lupus erythematosus	0.000406	0.0125	CbGeAlD
Meloxicam—CYP2C8—kidney—systemic lupus erythematosus	0.000377	0.0116	CbGeAlD
Meloxicam—ABCC4—lung—systemic lupus erythematosus	0.000368	0.0113	CbGeAlD
Meloxicam—PTGS1—connective tissue—systemic lupus erythematosus	0.000359	0.0111	CbGeAlD
Meloxicam—PTGS2—connective tissue—systemic lupus erythematosus	0.000343	0.0106	CbGeAlD
Meloxicam—ABCC4—nervous system—systemic lupus erythematosus	0.000341	0.0105	CbGeAlD
Meloxicam—ABCC4—central nervous system—systemic lupus erythematosus	0.000328	0.0101	CbGeAlD
Meloxicam—Piroxicam—PTGS2—systemic lupus erythematosus	0.000328	0.188	CrCbGaD
Meloxicam—PTGS1—skin of body—systemic lupus erythematosus	0.000324	0.01	CbGeAlD
Meloxicam—PTGS2—skin of body—systemic lupus erythematosus	0.00031	0.00956	CbGeAlD
Meloxicam—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000306	0.159	CbGdCrCtD
Meloxicam—PTGS1—kidney—systemic lupus erythematosus	0.000306	0.00943	CbGeAlD
Meloxicam—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000301	0.156	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000301	0.156	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000294	0.153	CbGdCrCtD
Meloxicam—PTGS2—kidney—systemic lupus erythematosus	0.000292	0.00901	CbGeAlD
Meloxicam—Piroxicam—ALB—systemic lupus erythematosus	0.000292	0.167	CrCbGaD
Meloxicam—CYP3A4—kidney—systemic lupus erythematosus	0.000255	0.00787	CbGeAlD
Meloxicam—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000251	0.00774	CbGeAlD
Meloxicam—PTGS1—tendon—systemic lupus erythematosus	0.000247	0.00761	CbGeAlD
Meloxicam—PTGS2—tendon—systemic lupus erythematosus	0.000236	0.00728	CbGeAlD
Meloxicam—PTGS2—bone marrow—systemic lupus erythematosus	0.000228	0.00705	CbGeAlD
Meloxicam—PTGS1—lung—systemic lupus erythematosus	0.000217	0.00668	CbGeAlD
Meloxicam—PTGS2—lung—systemic lupus erythematosus	0.000207	0.00638	CbGeAlD
Meloxicam—PTGS1—nervous system—systemic lupus erythematosus	0.000201	0.00619	CbGeAlD
Meloxicam—PTGS1—central nervous system—systemic lupus erythematosus	0.000193	0.00596	CbGeAlD
Meloxicam—PTGS2—nervous system—systemic lupus erythematosus	0.000192	0.00591	CbGeAlD
Meloxicam—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000185	0.0957	CbGdCrCtD
Meloxicam—PTGS2—central nervous system—systemic lupus erythematosus	0.000185	0.00569	CbGeAlD
Meloxicam—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000182	0.0942	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000182	0.0942	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000178	0.0921	CbGdCrCtD
Meloxicam—CYP3A4—nervous system—systemic lupus erythematosus	0.000167	0.00517	CbGeAlD
Meloxicam—CYP3A4—central nervous system—systemic lupus erythematosus	0.000161	0.00497	CbGeAlD
Meloxicam—Fatigue—Hydrocortisone—systemic lupus erythematosus	5.03e-05	0.00051	CcSEcCtD
Meloxicam—Vision blurred—Prednisone—systemic lupus erythematosus	5.02e-05	0.000508	CcSEcCtD
Meloxicam—Urethral disorder—Methotrexate—systemic lupus erythematosus	5.01e-05	0.000508	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	5.01e-05	0.000508	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	5e-05	0.000506	CcSEcCtD
Meloxicam—Pain—Hydrocortisone—systemic lupus erythematosus	4.99e-05	0.000506	CcSEcCtD
Meloxicam—Oedema—Betamethasone—systemic lupus erythematosus	4.99e-05	0.000506	CcSEcCtD
Meloxicam—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	4.99e-05	0.000506	CcSEcCtD
Meloxicam—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	4.99e-05	0.000506	CcSEcCtD
Meloxicam—Oedema—Dexamethasone—systemic lupus erythematosus	4.99e-05	0.000506	CcSEcCtD
Meloxicam—Insomnia—Triamcinolone—systemic lupus erythematosus	4.97e-05	0.000504	CcSEcCtD
Meloxicam—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.96e-05	0.000503	CcSEcCtD
Meloxicam—Infection—Betamethasone—systemic lupus erythematosus	4.95e-05	0.000502	CcSEcCtD
Meloxicam—Infection—Dexamethasone—systemic lupus erythematosus	4.95e-05	0.000502	CcSEcCtD
Meloxicam—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.94e-05	0.0005	CcSEcCtD
Meloxicam—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.94e-05	0.0005	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.93e-05	0.000499	CcSEcCtD
Meloxicam—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.92e-05	0.000499	CcSEcCtD
Meloxicam—Visual impairment—Methotrexate—systemic lupus erythematosus	4.92e-05	0.000499	CcSEcCtD
Meloxicam—Anaemia—Prednisone—systemic lupus erythematosus	4.92e-05	0.000499	CcSEcCtD
Meloxicam—Shock—Dexamethasone—systemic lupus erythematosus	4.91e-05	0.000497	CcSEcCtD
Meloxicam—Shock—Betamethasone—systemic lupus erythematosus	4.91e-05	0.000497	CcSEcCtD
Meloxicam—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.9e-05	0.000497	CcSEcCtD
Meloxicam—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.89e-05	0.000496	CcSEcCtD
Meloxicam—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.89e-05	0.000496	CcSEcCtD
Meloxicam—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.88e-05	0.000495	CcSEcCtD
Meloxicam—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.88e-05	0.000495	CcSEcCtD
Meloxicam—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.87e-05	0.000493	CcSEcCtD
Meloxicam—Tachycardia—Betamethasone—systemic lupus erythematosus	4.87e-05	0.000493	CcSEcCtD
Meloxicam—Angioedema—Prednisone—systemic lupus erythematosus	4.86e-05	0.000493	CcSEcCtD
Meloxicam—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.84e-05	0.00049	CcSEcCtD
Meloxicam—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.84e-05	0.00049	CcSEcCtD
Meloxicam—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.83e-05	0.00049	CcSEcCtD
Meloxicam—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.83e-05	0.000489	CcSEcCtD
Meloxicam—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.82e-05	0.000489	CcSEcCtD
Meloxicam—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.82e-05	0.000489	CcSEcCtD
Meloxicam—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.81e-05	0.000488	CcSEcCtD
Meloxicam—Malaise—Prednisone—systemic lupus erythematosus	4.8e-05	0.000486	CcSEcCtD
Meloxicam—Vertigo—Prednisone—systemic lupus erythematosus	4.78e-05	0.000485	CcSEcCtD
Meloxicam—Eye disorder—Methotrexate—systemic lupus erythematosus	4.77e-05	0.000484	CcSEcCtD
Meloxicam—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.77e-05	0.000484	CcSEcCtD
Meloxicam—Syncope—Prednisone—systemic lupus erythematosus	4.77e-05	0.000484	CcSEcCtD
Meloxicam—Tinnitus—Methotrexate—systemic lupus erythematosus	4.76e-05	0.000483	CcSEcCtD
Meloxicam—Urticaria—Prednisolone—systemic lupus erythematosus	4.75e-05	0.000481	CcSEcCtD
Meloxicam—Cardiac disorder—Methotrexate—systemic lupus erythematosus	4.74e-05	0.000481	CcSEcCtD
Meloxicam—Fatigue—Triamcinolone—systemic lupus erythematosus	4.74e-05	0.00048	CcSEcCtD
Meloxicam—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.73e-05	0.000479	CcSEcCtD
Meloxicam—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.72e-05	0.000478	CcSEcCtD
Meloxicam—Asthenia—Cyclosporine—systemic lupus erythematosus	4.71e-05	0.000478	CcSEcCtD
Meloxicam—Pain—Triamcinolone—systemic lupus erythematosus	4.7e-05	0.000476	CcSEcCtD
Meloxicam—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.68e-05	0.000474	CcSEcCtD
Meloxicam—Hypotension—Dexamethasone—systemic lupus erythematosus	4.66e-05	0.000472	CcSEcCtD
Meloxicam—Hypotension—Betamethasone—systemic lupus erythematosus	4.66e-05	0.000472	CcSEcCtD
Meloxicam—Pruritus—Cyclosporine—systemic lupus erythematosus	4.65e-05	0.000471	CcSEcCtD
Meloxicam—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.64e-05	0.00047	CcSEcCtD
Meloxicam—Angiopathy—Methotrexate—systemic lupus erythematosus	4.64e-05	0.00047	CcSEcCtD
Meloxicam—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000468	CcSEcCtD
Meloxicam—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.61e-05	0.000468	CcSEcCtD
Meloxicam—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.61e-05	0.000468	CcSEcCtD
Meloxicam—Convulsion—Prednisone—systemic lupus erythematosus	4.61e-05	0.000467	CcSEcCtD
Meloxicam—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.6e-05	0.000467	CcSEcCtD
Meloxicam—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.6e-05	0.000466	CcSEcCtD
Meloxicam—Hypertension—Prednisone—systemic lupus erythematosus	4.59e-05	0.000466	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.54e-05	0.000461	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.54e-05	0.000461	CcSEcCtD
Meloxicam—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.53e-05	0.000459	CcSEcCtD
Meloxicam—Arthralgia—Prednisone—systemic lupus erythematosus	4.53e-05	0.000459	CcSEcCtD
Meloxicam—Myalgia—Prednisone—systemic lupus erythematosus	4.53e-05	0.000459	CcSEcCtD
Meloxicam—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.53e-05	0.000459	CcSEcCtD
Meloxicam—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.52e-05	0.000458	CcSEcCtD
Meloxicam—Anxiety—Prednisone—systemic lupus erythematosus	4.51e-05	0.000458	CcSEcCtD
Meloxicam—Alopecia—Methotrexate—systemic lupus erythematosus	4.51e-05	0.000458	CcSEcCtD
Meloxicam—Insomnia—Dexamethasone—systemic lupus erythematosus	4.51e-05	0.000457	CcSEcCtD
Meloxicam—Insomnia—Betamethasone—systemic lupus erythematosus	4.51e-05	0.000457	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.5e-05	0.000456	CcSEcCtD
Meloxicam—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.49e-05	0.000456	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.48e-05	0.000455	CcSEcCtD
Meloxicam—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.48e-05	0.000454	CcSEcCtD
Meloxicam—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.48e-05	0.000454	CcSEcCtD
Meloxicam—Discomfort—Prednisone—systemic lupus erythematosus	4.48e-05	0.000454	CcSEcCtD
Meloxicam—Mental disorder—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000454	CcSEcCtD
Meloxicam—Malnutrition—Methotrexate—systemic lupus erythematosus	4.45e-05	0.000451	CcSEcCtD
Meloxicam—Erythema—Methotrexate—systemic lupus erythematosus	4.45e-05	0.000451	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.4e-05	0.000446	CcSEcCtD
Meloxicam—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.39e-05	0.000445	CcSEcCtD
Meloxicam—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.39e-05	0.000445	CcSEcCtD
Meloxicam—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.38e-05	0.000444	CcSEcCtD
Meloxicam—Urticaria—Triamcinolone—systemic lupus erythematosus	4.37e-05	0.000443	CcSEcCtD
Meloxicam—Urticaria—Methylprednisolone—systemic lupus erythematosus	4.36e-05	0.000442	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—systemic lupus erythematosus	4.36e-05	0.000441	CcSEcCtD
Meloxicam—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.34e-05	0.00044	CcSEcCtD
Meloxicam—Dizziness—Cyclosporine—systemic lupus erythematosus	4.34e-05	0.00044	CcSEcCtD
Meloxicam—Anaphylactic shock—Prednisone—systemic lupus erythematosus	4.34e-05	0.00044	CcSEcCtD
Meloxicam—Oedema—Prednisone—systemic lupus erythematosus	4.34e-05	0.00044	CcSEcCtD
Meloxicam—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.34e-05	0.000439	CcSEcCtD
Meloxicam—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.34e-05	0.000439	CcSEcCtD
Meloxicam—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.000439	CcSEcCtD
Meloxicam—Infection—Prednisone—systemic lupus erythematosus	4.31e-05	0.000437	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.31e-05	0.000436	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.31e-05	0.000436	CcSEcCtD
Meloxicam—Back pain—Methotrexate—systemic lupus erythematosus	4.3e-05	0.000436	CcSEcCtD
Meloxicam—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.3e-05	0.000436	CcSEcCtD
Meloxicam—Fatigue—Dexamethasone—systemic lupus erythematosus	4.3e-05	0.000436	CcSEcCtD
Meloxicam—Fatigue—Betamethasone—systemic lupus erythematosus	4.3e-05	0.000436	CcSEcCtD
Meloxicam—Shock—Prednisone—systemic lupus erythematosus	4.27e-05	0.000433	CcSEcCtD
Meloxicam—Pain—Dexamethasone—systemic lupus erythematosus	4.26e-05	0.000432	CcSEcCtD
Meloxicam—Pain—Betamethasone—systemic lupus erythematosus	4.26e-05	0.000432	CcSEcCtD
Meloxicam—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.26e-05	0.000432	CcSEcCtD
Meloxicam—Tachycardia—Prednisone—systemic lupus erythematosus	4.24e-05	0.00043	CcSEcCtD
Meloxicam—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.24e-05	0.000429	CcSEcCtD
Meloxicam—Skin disorder—Prednisone—systemic lupus erythematosus	4.22e-05	0.000428	CcSEcCtD
Meloxicam—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.2e-05	0.000426	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—systemic lupus erythematosus	4.19e-05	0.000425	CcSEcCtD
Meloxicam—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.19e-05	0.000425	CcSEcCtD
Meloxicam—Vomiting—Cyclosporine—systemic lupus erythematosus	4.18e-05	0.000423	CcSEcCtD
Meloxicam—Rash—Cyclosporine—systemic lupus erythematosus	4.14e-05	0.00042	CcSEcCtD
Meloxicam—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.14e-05	0.000419	CcSEcCtD
Meloxicam—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.13e-05	0.000419	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.13e-05	0.000418	CcSEcCtD
Meloxicam—Headache—Cyclosporine—systemic lupus erythematosus	4.11e-05	0.000417	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—systemic lupus erythematosus	4.11e-05	0.000417	CcSEcCtD
Meloxicam—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.11e-05	0.000417	CcSEcCtD
Meloxicam—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.11e-05	0.000417	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.08e-05	0.000413	CcSEcCtD
Meloxicam—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.08e-05	0.000413	CcSEcCtD
Meloxicam—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.07e-05	0.000413	CcSEcCtD
Meloxicam—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.05e-05	0.00041	CcSEcCtD
Meloxicam—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.04e-05	0.00041	CcSEcCtD
Meloxicam—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.04e-05	0.000409	CcSEcCtD
Meloxicam—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.04e-05	0.000409	CcSEcCtD
Meloxicam—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.01e-05	0.000407	CcSEcCtD
Meloxicam—Malaise—Methotrexate—systemic lupus erythematosus	4.01e-05	0.000407	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—systemic lupus erythematosus	4e-05	0.000405	CcSEcCtD
Meloxicam—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.99e-05	0.000405	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000404	CcSEcCtD
Meloxicam—Urticaria—Betamethasone—systemic lupus erythematosus	3.96e-05	0.000402	CcSEcCtD
Meloxicam—Urticaria—Dexamethasone—systemic lupus erythematosus	3.96e-05	0.000402	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.96e-05	0.000401	CcSEcCtD
Meloxicam—Dizziness—Prednisolone—systemic lupus erythematosus	3.95e-05	0.000401	CcSEcCtD
Meloxicam—Asthenia—Triamcinolone—systemic lupus erythematosus	3.94e-05	0.0004	CcSEcCtD
Meloxicam—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.0004	CcSEcCtD
Meloxicam—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.94e-05	0.0004	CcSEcCtD
Meloxicam—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.94e-05	0.0004	CcSEcCtD
Meloxicam—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.0004	CcSEcCtD
Meloxicam—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.93e-05	0.000399	CcSEcCtD
Meloxicam—Insomnia—Prednisone—systemic lupus erythematosus	3.93e-05	0.000398	CcSEcCtD
Meloxicam—Nausea—Cyclosporine—systemic lupus erythematosus	3.9e-05	0.000395	CcSEcCtD
Meloxicam—Paraesthesia—Prednisone—systemic lupus erythematosus	3.9e-05	0.000395	CcSEcCtD
Meloxicam—Pruritus—Triamcinolone—systemic lupus erythematosus	3.89e-05	0.000394	CcSEcCtD
Meloxicam—Cough—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000393	CcSEcCtD
Meloxicam—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.88e-05	0.000393	CcSEcCtD
Meloxicam—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.86e-05	0.000391	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—systemic lupus erythematosus	3.85e-05	0.000391	CcSEcCtD
Meloxicam—Dyspepsia—Prednisone—systemic lupus erythematosus	3.82e-05	0.000388	CcSEcCtD
Meloxicam—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.81e-05	0.000386	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—systemic lupus erythematosus	3.79e-05	0.000384	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—systemic lupus erythematosus	3.79e-05	0.000384	CcSEcCtD
Meloxicam—Decreased appetite—Prednisone—systemic lupus erythematosus	3.78e-05	0.000383	CcSEcCtD
Meloxicam—Rash—Prednisolone—systemic lupus erythematosus	3.77e-05	0.000382	CcSEcCtD
Meloxicam—Dermatitis—Prednisolone—systemic lupus erythematosus	3.76e-05	0.000382	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000381	CcSEcCtD
Meloxicam—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.75e-05	0.00038	CcSEcCtD
Meloxicam—Fatigue—Prednisone—systemic lupus erythematosus	3.74e-05	0.00038	CcSEcCtD
Meloxicam—Headache—Prednisolone—systemic lupus erythematosus	3.74e-05	0.00038	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000379	CcSEcCtD
Meloxicam—Constipation—Prednisone—systemic lupus erythematosus	3.71e-05	0.000376	CcSEcCtD
Meloxicam—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.71e-05	0.000376	CcSEcCtD
Meloxicam—Rash—Hydrocortisone—systemic lupus erythematosus	3.68e-05	0.000373	CcSEcCtD
Meloxicam—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.68e-05	0.000373	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—systemic lupus erythematosus	3.66e-05	0.000371	CcSEcCtD
Meloxicam—Headache—Hydrocortisone—systemic lupus erythematosus	3.66e-05	0.000371	CcSEcCtD
Meloxicam—Dizziness—Triamcinolone—systemic lupus erythematosus	3.63e-05	0.000368	CcSEcCtD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	3.63e-05	0.0131	CbGpPWpGaD
Meloxicam—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	3.63e-05	0.000368	CcSEcCtD
Meloxicam—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.000368	CcSEcCtD
Meloxicam—Infection—Methotrexate—systemic lupus erythematosus	3.61e-05	0.000366	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.58e-05	0.000363	CcSEcCtD
Meloxicam—Asthenia—Betamethasone—systemic lupus erythematosus	3.58e-05	0.000363	CcSEcCtD
Meloxicam—Asthenia—Dexamethasone—systemic lupus erythematosus	3.58e-05	0.000363	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.56e-05	0.000361	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.55e-05	0.00036	CcSEcCtD
Meloxicam—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.55e-05	0.00036	CcSEcCtD
Meloxicam—Nausea—Prednisolone—systemic lupus erythematosus	3.55e-05	0.00036	CcSEcCtD
Meloxicam—Pruritus—Dexamethasone—systemic lupus erythematosus	3.53e-05	0.000358	CcSEcCtD
Meloxicam—Pruritus—Betamethasone—systemic lupus erythematosus	3.53e-05	0.000358	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—systemic lupus erythematosus	3.53e-05	0.000357	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.51e-05	0.000356	CcSEcCtD
Meloxicam—Vomiting—Triamcinolone—systemic lupus erythematosus	3.49e-05	0.000354	CcSEcCtD
Meloxicam—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.49e-05	0.000353	CcSEcCtD
Meloxicam—Nausea—Hydrocortisone—systemic lupus erythematosus	3.47e-05	0.000351	CcSEcCtD
Meloxicam—Rash—Triamcinolone—systemic lupus erythematosus	3.47e-05	0.000351	CcSEcCtD
Meloxicam—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.46e-05	0.000351	CcSEcCtD
Meloxicam—Rash—Methylprednisolone—systemic lupus erythematosus	3.46e-05	0.00035	CcSEcCtD
Meloxicam—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.45e-05	0.00035	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	3.45e-05	0.0124	CbGpPWpGaD
Meloxicam—Urticaria—Prednisone—systemic lupus erythematosus	3.45e-05	0.00035	CcSEcCtD
Meloxicam—Headache—Triamcinolone—systemic lupus erythematosus	3.44e-05	0.000349	CcSEcCtD
Meloxicam—Headache—Methylprednisolone—systemic lupus erythematosus	3.44e-05	0.000348	CcSEcCtD
Meloxicam—Abdominal pain—Prednisone—systemic lupus erythematosus	3.43e-05	0.000348	CcSEcCtD
Meloxicam—Body temperature increased—Prednisone—systemic lupus erythematosus	3.43e-05	0.000348	CcSEcCtD
Meloxicam—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.41e-05	0.000346	CcSEcCtD
Meloxicam—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.41e-05	0.000346	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000344	CcSEcCtD
Meloxicam—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	3.37e-05	0.0121	CbGpPWpGaD
Meloxicam—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	3.32e-05	0.012	CbGpPWpGaD
Meloxicam—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	3.32e-05	0.012	CbGpPWpGaD
Meloxicam—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.31e-05	0.000335	CcSEcCtD
Meloxicam—Dizziness—Dexamethasone—systemic lupus erythematosus	3.3e-05	0.000334	CcSEcCtD
Meloxicam—Dizziness—Betamethasone—systemic lupus erythematosus	3.3e-05	0.000334	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—systemic lupus erythematosus	3.28e-05	0.000333	CcSEcCtD
Meloxicam—Nausea—Triamcinolone—systemic lupus erythematosus	3.26e-05	0.000331	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.26e-05	0.00033	CcSEcCtD
Meloxicam—Nausea—Methylprednisolone—systemic lupus erythematosus	3.26e-05	0.00033	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000328	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—systemic lupus erythematosus	3.23e-05	0.000327	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.2e-05	0.000324	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000324	CcSEcCtD
Meloxicam—Vomiting—Betamethasone—systemic lupus erythematosus	3.17e-05	0.000321	CcSEcCtD
Meloxicam—Vomiting—Dexamethasone—systemic lupus erythematosus	3.17e-05	0.000321	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.16e-05	0.00032	CcSEcCtD
Meloxicam—Rash—Dexamethasone—systemic lupus erythematosus	3.14e-05	0.000319	CcSEcCtD
Meloxicam—Rash—Betamethasone—systemic lupus erythematosus	3.14e-05	0.000319	CcSEcCtD
Meloxicam—Dermatitis—Betamethasone—systemic lupus erythematosus	3.14e-05	0.000318	CcSEcCtD
Meloxicam—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.14e-05	0.000318	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000318	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000317	CcSEcCtD
Meloxicam—Headache—Betamethasone—systemic lupus erythematosus	3.12e-05	0.000317	CcSEcCtD
Meloxicam—Headache—Dexamethasone—systemic lupus erythematosus	3.12e-05	0.000317	CcSEcCtD
Meloxicam—Asthenia—Prednisone—systemic lupus erythematosus	3.12e-05	0.000316	CcSEcCtD
Meloxicam—Pain—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000315	CcSEcCtD
Meloxicam—Pruritus—Prednisone—systemic lupus erythematosus	3.07e-05	0.000311	CcSEcCtD
Meloxicam—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000303	CcSEcCtD
Meloxicam—Diarrhoea—Prednisone—systemic lupus erythematosus	2.97e-05	0.000301	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.97e-05	0.000301	CcSEcCtD
Meloxicam—Nausea—Betamethasone—systemic lupus erythematosus	2.96e-05	0.0003	CcSEcCtD
Meloxicam—Nausea—Dexamethasone—systemic lupus erythematosus	2.96e-05	0.0003	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—systemic lupus erythematosus	2.88e-05	0.000292	CcSEcCtD
Meloxicam—Dizziness—Prednisone—systemic lupus erythematosus	2.87e-05	0.000291	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.87e-05	0.000291	CcSEcCtD
Meloxicam—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.87e-05	0.000291	CcSEcCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	2.86e-05	0.0103	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	2.84e-05	0.0103	CbGpPWpGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	2.78e-05	0.01	CbGpPWpGaD
Meloxicam—Vomiting—Prednisone—systemic lupus erythematosus	2.76e-05	0.00028	CcSEcCtD
Meloxicam—Rash—Prednisone—systemic lupus erythematosus	2.74e-05	0.000278	CcSEcCtD
Meloxicam—Dermatitis—Prednisone—systemic lupus erythematosus	2.74e-05	0.000277	CcSEcCtD
Meloxicam—Headache—Prednisone—systemic lupus erythematosus	2.72e-05	0.000276	CcSEcCtD
Meloxicam—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000271	CcSEcCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	2.65e-05	0.00958	CbGpPWpGaD
Meloxicam—Asthenia—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000264	CcSEcCtD
Meloxicam—Nausea—Prednisone—systemic lupus erythematosus	2.58e-05	0.000261	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—systemic lupus erythematosus	2.57e-05	0.00026	CcSEcCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	2.55e-05	0.00918	CbGpPWpGaD
Meloxicam—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.48e-05	0.000252	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000243	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	2.39e-05	0.00863	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	2.37e-05	0.00857	CbGpPWpGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	2.36e-05	0.00851	CbGpPWpGaD
Meloxicam—Vomiting—Methotrexate—systemic lupus erythematosus	2.31e-05	0.000234	CcSEcCtD
Meloxicam—Rash—Methotrexate—systemic lupus erythematosus	2.29e-05	0.000232	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—systemic lupus erythematosus	2.29e-05	0.000232	CcSEcCtD
Meloxicam—Headache—Methotrexate—systemic lupus erythematosus	2.27e-05	0.00023	CcSEcCtD
Meloxicam—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	2.21e-05	0.00798	CbGpPWpGaD
Meloxicam—Nausea—Methotrexate—systemic lupus erythematosus	2.16e-05	0.000219	CcSEcCtD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	2.04e-05	0.00736	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	2.04e-05	0.00735	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2e-05	0.00722	CbGpPWpGaD
Meloxicam—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	1.99e-05	0.00716	CbGpPWpGaD
Meloxicam—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	1.98e-05	0.00716	CbGpPWpGaD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	1.97e-05	0.00712	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	1.97e-05	0.00711	CbGpPWpGaD
Meloxicam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	1.97e-05	0.00709	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	1.96e-05	0.00708	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	1.92e-05	0.00693	CbGpPWpGaD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.85e-05	0.00667	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	1.85e-05	0.00666	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	1.81e-05	0.00655	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	1.8e-05	0.00648	CbGpPWpGaD
Meloxicam—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	1.78e-05	0.00642	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	1.75e-05	0.00632	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	1.72e-05	0.00619	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	1.71e-05	0.00617	CbGpPWpGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	1.68e-05	0.00606	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	1.65e-05	0.00595	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	1.65e-05	0.00594	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—RXRA—systemic lupus erythematosus	1.59e-05	0.00574	CbGpPWpGaD
Meloxicam—PGD—Disease—XRCC6—systemic lupus erythematosus	1.58e-05	0.00571	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	1.55e-05	0.00559	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	1.52e-05	0.0055	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	1.5e-05	0.00543	CbGpPWpGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	1.49e-05	0.00538	CbGpPWpGaD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	1.47e-05	0.00532	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—ALB—systemic lupus erythematosus	1.46e-05	0.00527	CbGpPWpGaD
Meloxicam—PGD—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.43e-05	0.00517	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—systemic lupus erythematosus	1.39e-05	0.00502	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	1.32e-05	0.00477	CbGpPWpGaD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	1.31e-05	0.00473	CbGpPWpGaD
Meloxicam—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	1.31e-05	0.00472	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	1.28e-05	0.0046	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	1.24e-05	0.00449	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	1.24e-05	0.00446	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	1.23e-05	0.00444	CbGpPWpGaD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	1.2e-05	0.00433	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.2e-05	0.00431	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	1.19e-05	0.0043	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—ITGAX—systemic lupus erythematosus	1.18e-05	0.00425	CbGpPWpGaD
Meloxicam—PGD—Disease—HIST2H2AC—systemic lupus erythematosus	1.17e-05	0.00421	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—F3—systemic lupus erythematosus	1.16e-05	0.00419	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	1.15e-05	0.00414	CbGpPWpGaD
Meloxicam—PGD—Disease—CSK—systemic lupus erythematosus	1.14e-05	0.0041	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	1.13e-05	0.00409	CbGpPWpGaD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	1.13e-05	0.00407	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.12e-05	0.00403	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	1.09e-05	0.00392	CbGpPWpGaD
Meloxicam—PGD—Disease—CD247—systemic lupus erythematosus	1.07e-05	0.00386	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NAT2—systemic lupus erythematosus	1.07e-05	0.00386	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	1.05e-05	0.0038	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CLU—systemic lupus erythematosus	1.05e-05	0.00379	CbGpPWpGaD
Meloxicam—PGD—Disease—NCF2—systemic lupus erythematosus	1.04e-05	0.00375	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	1.02e-05	0.00369	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—P2RY12—systemic lupus erythematosus	1.02e-05	0.00367	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—CCL2—systemic lupus erythematosus	1.01e-05	0.00366	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—VEGFA—systemic lupus erythematosus	1.01e-05	0.00363	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	9.88e-06	0.00356	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	9.83e-06	0.00355	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	9.73e-06	0.00351	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.73e-06	0.00351	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	9.65e-06	0.00348	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	9.6e-06	0.00346	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	9.59e-06	0.00346	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	9.54e-06	0.00344	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SELE—systemic lupus erythematosus	9.36e-06	0.00337	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CSK—systemic lupus erythematosus	9.36e-06	0.00337	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	9.26e-06	0.00334	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—TGFB1—systemic lupus erythematosus	9.24e-06	0.00333	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	9.22e-06	0.00332	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	9.12e-06	0.00329	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.09e-06	0.00328	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	9.04e-06	0.00326	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	8.96e-06	0.00323	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	8.8e-06	0.00318	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—ITGAM—systemic lupus erythematosus	8.8e-06	0.00317	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	8.77e-06	0.00316	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	8.7e-06	0.00314	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	8.68e-06	0.00313	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—LYN—systemic lupus erythematosus	8.5e-06	0.00307	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	8.47e-06	0.00306	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	8.34e-06	0.00301	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SH2B3—systemic lupus erythematosus	8.34e-06	0.00301	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	8.19e-06	0.00295	CbGpPWpGaD
Meloxicam—PGD—Disease—JUNB—systemic lupus erythematosus	8.16e-06	0.00295	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	8.13e-06	0.00293	CbGpPWpGaD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	7.91e-06	0.00285	CbGpPWpGaD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	7.87e-06	0.00284	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	7.8e-06	0.00281	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	7.57e-06	0.00273	CbGpPWpGaD
Meloxicam—PGD—Disease—PRL—systemic lupus erythematosus	7.52e-06	0.00271	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	7.51e-06	0.00271	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	7.49e-06	0.0027	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	7.17e-06	0.00259	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	7.03e-06	0.00254	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	6.93e-06	0.0025	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	6.91e-06	0.00249	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.9e-06	0.00249	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IFNA1—systemic lupus erythematosus	6.55e-06	0.00236	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	6.51e-06	0.00235	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	6.48e-06	0.00234	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	6.43e-06	0.00232	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.41e-06	0.00231	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—RASGRP1—systemic lupus erythematosus	6.38e-06	0.0023	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	6.35e-06	0.00229	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	6.08e-06	0.00219	CbGpPWpGaD
Meloxicam—PGD—Disease—JAK1—systemic lupus erythematosus	6.02e-06	0.00217	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	6.01e-06	0.00217	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.99e-06	0.00216	CbGpPWpGaD
Meloxicam—PGD—Metabolism—RXRA—systemic lupus erythematosus	5.99e-06	0.00216	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	5.88e-06	0.00212	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	5.72e-06	0.00206	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFB1—systemic lupus erythematosus	5.71e-06	0.00206	CbGpPWpGaD
Meloxicam—PGD—Disease—CCR5—systemic lupus erythematosus	5.7e-06	0.00206	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	5.67e-06	0.00204	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	5.63e-06	0.00203	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	5.46e-06	0.00197	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	5.26e-06	0.0019	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	5.17e-06	0.00186	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.09e-06	0.00184	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	4.96e-06	0.00179	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—JAK1—systemic lupus erythematosus	4.95e-06	0.00178	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	4.86e-06	0.00175	CbGpPWpGaD
Meloxicam—PGD—Disease—CD80—systemic lupus erythematosus	4.69e-06	0.00169	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2RA—systemic lupus erythematosus	4.62e-06	0.00167	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	4.6e-06	0.00166	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	4.55e-06	0.00164	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	4.47e-06	0.00161	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	4.47e-06	0.00161	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	4.1e-06	0.00148	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—F2—systemic lupus erythematosus	4.02e-06	0.00145	CbGpPWpGaD
Meloxicam—PGD—Disease—TYK2—systemic lupus erythematosus	3.96e-06	0.00143	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS3—systemic lupus erythematosus	3.89e-06	0.0014	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	3.79e-06	0.00137	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PPARG—systemic lupus erythematosus	3.78e-06	0.00136	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.77e-06	0.00136	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	3.61e-06	0.0013	CbGpPWpGaD
Meloxicam—PGD—Disease—CD4—systemic lupus erythematosus	3.58e-06	0.00129	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—systemic lupus erythematosus	3.55e-06	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	3.54e-06	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Disease—XRCC6—systemic lupus erythematosus	3.53e-06	0.00127	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.41e-06	0.00123	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ALB—systemic lupus erythematosus	3.4e-06	0.00123	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	3.38e-06	0.00122	CbGpPWpGaD
Meloxicam—PGD—Disease—CDKN1B—systemic lupus erythematosus	3.37e-06	0.00121	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—ALB—systemic lupus erythematosus	3.34e-06	0.00121	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NOS3—systemic lupus erythematosus	3.25e-06	0.00117	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NOS3—systemic lupus erythematosus	3.2e-06	0.00115	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.11e-06	0.00112	CbGpPWpGaD
Meloxicam—PGD—Disease—CDKN1A—systemic lupus erythematosus	3.11e-06	0.00112	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	3e-06	0.00108	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3e-06	0.00108	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—systemic lupus erythematosus	2.98e-06	0.00107	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.96e-06	0.00107	CbGpPWpGaD
Meloxicam—PGD—Disease—EP300—systemic lupus erythematosus	2.96e-06	0.00107	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.89e-06	0.00104	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	2.85e-06	0.00103	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.81e-06	0.00101	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—systemic lupus erythematosus	2.71e-06	0.000977	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	2.6e-06	0.000938	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.58e-06	0.000929	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—systemic lupus erythematosus	2.57e-06	0.000927	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CSK—systemic lupus erythematosus	2.53e-06	0.000914	CbGpPWpGaD
Meloxicam—PGD—Metabolism—EP300—systemic lupus erythematosus	2.48e-06	0.000893	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.44e-06	0.000879	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—EP300—systemic lupus erythematosus	2.43e-06	0.000877	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.41e-06	0.000868	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.38e-06	0.00086	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD247—systemic lupus erythematosus	2.38e-06	0.000859	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	2.38e-06	0.000859	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NCF2—systemic lupus erythematosus	2.32e-06	0.000836	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—systemic lupus erythematosus	2.3e-06	0.00083	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.14e-06	0.000773	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—systemic lupus erythematosus	2.11e-06	0.000762	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.98e-06	0.000716	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.94e-06	0.000699	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—systemic lupus erythematosus	1.94e-06	0.000698	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.89e-06	0.000682	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.87e-06	0.000676	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JUNB—systemic lupus erythematosus	1.82e-06	0.000656	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.7e-06	0.000614	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.68e-06	0.000606	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PRL—systemic lupus erythematosus	1.68e-06	0.000604	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.58e-06	0.000569	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.56e-06	0.000562	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.54e-06	0.000555	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.38e-06	0.000499	CbGpPWpGaD
Meloxicam—PTGS2—Disease—JAK1—systemic lupus erythematosus	1.34e-06	0.000483	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	1.33e-06	0.000481	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CCR5—systemic lupus erythematosus	1.27e-06	0.000458	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.25e-06	0.000452	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.24e-06	0.000446	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.21e-06	0.000437	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.13e-06	0.000406	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.09e-06	0.000392	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	1.06e-06	0.000383	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD80—systemic lupus erythematosus	1.04e-06	0.000377	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.04e-06	0.000375	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.01e-06	0.000363	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.85e-07	0.000355	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—systemic lupus erythematosus	9.54e-07	0.000344	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	9.13e-07	0.000329	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	8.84e-07	0.000319	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TYK2—systemic lupus erythematosus	8.81e-07	0.000318	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—systemic lupus erythematosus	8.65e-07	0.000312	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	8.42e-07	0.000304	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	8.35e-07	0.000301	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.2e-07	0.000296	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD4—systemic lupus erythematosus	7.97e-07	0.000288	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—systemic lupus erythematosus	7.58e-07	0.000273	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	7.5e-07	0.00027	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	7.25e-07	0.000261	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—EP300—systemic lupus erythematosus	6.94e-07	0.00025	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	6.92e-07	0.00025	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	6.85e-07	0.000247	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EP300—systemic lupus erythematosus	6.58e-07	0.000237	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	6.16e-07	0.000222	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	5.9e-07	0.000213	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.83e-07	0.00021	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—systemic lupus erythematosus	5.72e-07	0.000206	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.58e-07	0.000201	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—EP300—systemic lupus erythematosus	5.51e-07	0.000199	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5.39e-07	0.000195	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	5.02e-07	0.000181	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.8e-07	0.000173	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.48e-07	0.000162	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.39e-07	0.000158	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—systemic lupus erythematosus	4.31e-07	0.000156	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.68e-07	0.000133	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.65e-07	0.000132	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.31e-07	0.000119	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.16e-07	0.000114	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.89e-07	0.000104	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.41e-07	8.68e-05	CbGpPWpGaD
